Chexbres, Switzerland

George Coukos

This inventor holds 5 USPTO granted patents and 11 published patent applications and 1 EPO patent. Top assignees: Ludwig Institute for Cancer Research Limited, Université De Lausanne, Centre Hospitalier Universitaire Vaudois. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Coukos. Retrieved from https://idiyas.com/inventor/george-coukos-33ueqck1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Inventor George Coukos

Introduction: George Coukos, a talented inventor hailing from Chexbres, Switzerland, has made significant contributions to the field of kinase mutants with his groundbreaking patent "Kinase mutants and uses thereof." This patent revolutionizes methods for reprogramming the sensitivity of target kinases to specific inhibitors, holding immense promise for the prevention and treatment of diseases, particularly cancer.

Latest Patents: With an impressive portfolio of one patented invention, George Coukos has demonstrated his expertise in the intricate realm of kinase mutants and their therapeutic applications. His patent serves as a beacon of hope for the development of innovative treatment strategies in the fight against cancer and other disorders.

Career Highlights: George Coukos has left an indelible mark on the scientific community through his work at esteemed institutions such as the SIB Swiss Institute of Bioinformatics and CHUV—Centre Hospitalier Universitaire Vaudois. His dedication to pioneering research has garnered recognition for his exceptional contributions to the field of bioinformatics and molecular biology.

Collaborations: Throughout his illustrious career, George Coukos has had the privilege of collaborating with esteemed colleagues such as Olivier Michielin and Vincent Zoete. Together, they have synergized their expertise to propel forward cutting-edge research initiatives and drive innovation in the realm of kinase mutants and their therapeutic applications.

Conclusion: George Coukos stands as a beacon of innovation and ingenuity in the realm of kinase mutants and their potential in disease prevention and treatment. His pioneering work continues to inspire and drive advancements in the field of molecular biology, laying the foundation for a brighter and healthier future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…